Landmark Papers in Psychiatry
Herausgeber: Ryznar, Elizabeth; Csernansky, John G; Reinecke, Mark A; Pederson, Aderonke B
Landmark Papers in Psychiatry
Herausgeber: Ryznar, Elizabeth; Csernansky, John G; Reinecke, Mark A; Pederson, Aderonke B
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Landmark Papers in Psychiatry traces the evolution of psychiatry as a scientific discipline. By summarizing over 100 watershed psychiatric papers this text gives historical context to the research trajectory of psychiatry.
Andere Kunden interessierten sich auch für
- 50 Landmark Papers Every Spine Surgeon Should Know64,99 €
- Katharine BoursicotOxford Assess and Progress: Psychiatry55,99 €
- Jonathan BurnsTextbook of Psychiatry for Southern Africa84,99 €
- Nigel EastmanForensic Psychiatry83,99 €
- Psychiatry Board Review188,99 €
- Management of Sleep Disorders in Psychiatry165,99 €
- Neuroprogression in Psychiatry76,99 €
-
-
-
Landmark Papers in Psychiatry traces the evolution of psychiatry as a scientific discipline. By summarizing over 100 watershed psychiatric papers this text gives historical context to the research trajectory of psychiatry.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Oxford University Press
- Seitenzahl: 440
- Erscheinungstermin: 23. März 2020
- Englisch
- Abmessung: 244mm x 168mm x 25mm
- Gewicht: 748g
- ISBN-13: 9780198836506
- ISBN-10: 0198836503
- Artikelnr.: 57147446
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
- Verlag: Oxford University Press
- Seitenzahl: 440
- Erscheinungstermin: 23. März 2020
- Englisch
- Abmessung: 244mm x 168mm x 25mm
- Gewicht: 748g
- ISBN-13: 9780198836506
- ISBN-10: 0198836503
- Artikelnr.: 57147446
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
A graduate of Harvard College and Harvard Medical School, Dr. Elizabeth Ryznar is currently a fourth year psychiatry resident at the McGaw Medical Center of Northwestern University in Chicago, where she also completed the Medical Education Clinical Scholars Program. She received her M.Sc. in Comparative Social Policy from the University of Oxford and is fluent in Polish and Spanish. Her clinical and research interests include community psychiatry, childhood trauma, psychiatric diagnosis, and medical education. She has published several peer-reviewed articles and has presented at national meetings. Dr. Ryznar has been recognized by the American Psychiatric Association as a Leadership Fellow (2017-2019) and by the American College of Psychiatrists as a Laughlin Fellow (2018) and returning fellow (2019). Dr. Aderonke B. Pederson is a 4th year psychiatry resident at the McGaw Medical center of Northwestern University, serving as chief resident. She graduated from University of Chicago as a double major in biological sciences and international studies. She completed her medical degree at Northwestern's University Feinberg school of medicine and was an American Psychiatric Association diversity leadership fellow in 2017-2018. She is a recipient of federal funding through the APA SAMHSA fellowship (2018-2019), completing research in minority mental health with a focus on mental health stigma among underserved black minority women in an urban setting. She has reviewed books and published peer-reviewed articles. She is also working on a global health certificate program at her institution with a focus in Nigeria (West Africa) and designed a seminar in West Africa on mental health stigma awareness among young adults. Professor Mark A. Reinecke is Chief of Psychology in the Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Professor John G. Csernansky currently serves as the Gilman Professor and Chair in the Department of Psychiatry and Behavioral Sciences at the Northwestern University Feinberg School of Medicine. Previously, he served as the Gregory B. Couch Professor of Psychiatry at Washington University School of Medicine. His research interests include the neuroimaging of neuropsychiatric disorders, especially schizophrenia, clinical trials of cognition-enhancing drugs, and the development of new animal models for neuropsychiatric disorders.
* I. Foundational Topics
* 1: Awais Aftab and John G. Csernansky: Diagnosis and
conceptualization of mental illness
* 2: Elizabeth Ryznar and Harvey Whiteford: Epidemiology
* II. Pathogenesis
* 3: Elizabeth Ryznar and Herbert Y. Meltzer: The neurochemical basis
of psychiatric disorders
* 4: Edwin H. Cook Jr. and Marina Bayeva: Genetics
* 5: Ozan Toy, Emmalee Boyle, and Lynn E. DeLisi: Inflammatory
mechanisms, the immune system and psychiatric illness
* 6: Shaun M. Eack: Psychological and social factors
* III. Pharmacotherapy
* 7: David. V. Braitman and Juan. R. Bustillo: Schizophrenia
* 8: Jair C. Soares, Marsal Sanches, and Rodrigo Machado-Vieira:
Pharmacotherapy of mood disorders
* 9: Dan J. Stein: Pharmacotherapy of anxiety and related disorders
* 10: Jenni E. Farrow, Francisco Romo-Nava, and Melissa Delbello: Child
and adolescent psychiatry
* IV. Psychosocial interventions
* 11: Kevin S. McCarthy and Richard F. Summers: Psychodynamic therapy
* 12: Keith S. Dobson: Cognitive behavioral therapy
* 13: Amanda A. Uliaszek, Nadia Al-Dajani, Amanda Ferguson, and Zindel
V. Segal: Third wave psychotherapies
* 14: Mariam Ujeyl and Wulf Rössler: Psychosocial rehabilitation
* 15: Neil Jordan: Social and community psychiatry
* 16: Mark R. Dadds, Yixin Jiang, Valsamma Eapen, and Stephen Scott:
Child and adolescent psychiatry and psychology
* VI. Somatic Treatments
* 17: Keith G. Rasmussen: Electroconvulsive therapy
* 18: Kevin A. Caulfield and Mark S. George: Non-convulsive brain
stimulation
* 19: Paul E. Holtzheimer and Helen Mayberg: Subcallosal cingulate deep
brain stimulation for treatment-resistant depression
* VII. Special Considerations
* 20: Rachel E. Zettl and John Z. Sadler: Psychiatric ethics
* 21: Stephen H. Dinwiddie: Forensics
* 22: Danuta Wasserman, Marcus Sokolowski, and Carli Vladimir: Suicide
* 23: Robert D. Gibbons: Research methodology
* 1: Awais Aftab and John G. Csernansky: Diagnosis and
conceptualization of mental illness
* 2: Elizabeth Ryznar and Harvey Whiteford: Epidemiology
* II. Pathogenesis
* 3: Elizabeth Ryznar and Herbert Y. Meltzer: The neurochemical basis
of psychiatric disorders
* 4: Edwin H. Cook Jr. and Marina Bayeva: Genetics
* 5: Ozan Toy, Emmalee Boyle, and Lynn E. DeLisi: Inflammatory
mechanisms, the immune system and psychiatric illness
* 6: Shaun M. Eack: Psychological and social factors
* III. Pharmacotherapy
* 7: David. V. Braitman and Juan. R. Bustillo: Schizophrenia
* 8: Jair C. Soares, Marsal Sanches, and Rodrigo Machado-Vieira:
Pharmacotherapy of mood disorders
* 9: Dan J. Stein: Pharmacotherapy of anxiety and related disorders
* 10: Jenni E. Farrow, Francisco Romo-Nava, and Melissa Delbello: Child
and adolescent psychiatry
* IV. Psychosocial interventions
* 11: Kevin S. McCarthy and Richard F. Summers: Psychodynamic therapy
* 12: Keith S. Dobson: Cognitive behavioral therapy
* 13: Amanda A. Uliaszek, Nadia Al-Dajani, Amanda Ferguson, and Zindel
V. Segal: Third wave psychotherapies
* 14: Mariam Ujeyl and Wulf Rössler: Psychosocial rehabilitation
* 15: Neil Jordan: Social and community psychiatry
* 16: Mark R. Dadds, Yixin Jiang, Valsamma Eapen, and Stephen Scott:
Child and adolescent psychiatry and psychology
* VI. Somatic Treatments
* 17: Keith G. Rasmussen: Electroconvulsive therapy
* 18: Kevin A. Caulfield and Mark S. George: Non-convulsive brain
stimulation
* 19: Paul E. Holtzheimer and Helen Mayberg: Subcallosal cingulate deep
brain stimulation for treatment-resistant depression
* VII. Special Considerations
* 20: Rachel E. Zettl and John Z. Sadler: Psychiatric ethics
* 21: Stephen H. Dinwiddie: Forensics
* 22: Danuta Wasserman, Marcus Sokolowski, and Carli Vladimir: Suicide
* 23: Robert D. Gibbons: Research methodology
* I. Foundational Topics
* 1: Awais Aftab and John G. Csernansky: Diagnosis and
conceptualization of mental illness
* 2: Elizabeth Ryznar and Harvey Whiteford: Epidemiology
* II. Pathogenesis
* 3: Elizabeth Ryznar and Herbert Y. Meltzer: The neurochemical basis
of psychiatric disorders
* 4: Edwin H. Cook Jr. and Marina Bayeva: Genetics
* 5: Ozan Toy, Emmalee Boyle, and Lynn E. DeLisi: Inflammatory
mechanisms, the immune system and psychiatric illness
* 6: Shaun M. Eack: Psychological and social factors
* III. Pharmacotherapy
* 7: David. V. Braitman and Juan. R. Bustillo: Schizophrenia
* 8: Jair C. Soares, Marsal Sanches, and Rodrigo Machado-Vieira:
Pharmacotherapy of mood disorders
* 9: Dan J. Stein: Pharmacotherapy of anxiety and related disorders
* 10: Jenni E. Farrow, Francisco Romo-Nava, and Melissa Delbello: Child
and adolescent psychiatry
* IV. Psychosocial interventions
* 11: Kevin S. McCarthy and Richard F. Summers: Psychodynamic therapy
* 12: Keith S. Dobson: Cognitive behavioral therapy
* 13: Amanda A. Uliaszek, Nadia Al-Dajani, Amanda Ferguson, and Zindel
V. Segal: Third wave psychotherapies
* 14: Mariam Ujeyl and Wulf Rössler: Psychosocial rehabilitation
* 15: Neil Jordan: Social and community psychiatry
* 16: Mark R. Dadds, Yixin Jiang, Valsamma Eapen, and Stephen Scott:
Child and adolescent psychiatry and psychology
* VI. Somatic Treatments
* 17: Keith G. Rasmussen: Electroconvulsive therapy
* 18: Kevin A. Caulfield and Mark S. George: Non-convulsive brain
stimulation
* 19: Paul E. Holtzheimer and Helen Mayberg: Subcallosal cingulate deep
brain stimulation for treatment-resistant depression
* VII. Special Considerations
* 20: Rachel E. Zettl and John Z. Sadler: Psychiatric ethics
* 21: Stephen H. Dinwiddie: Forensics
* 22: Danuta Wasserman, Marcus Sokolowski, and Carli Vladimir: Suicide
* 23: Robert D. Gibbons: Research methodology
* 1: Awais Aftab and John G. Csernansky: Diagnosis and
conceptualization of mental illness
* 2: Elizabeth Ryznar and Harvey Whiteford: Epidemiology
* II. Pathogenesis
* 3: Elizabeth Ryznar and Herbert Y. Meltzer: The neurochemical basis
of psychiatric disorders
* 4: Edwin H. Cook Jr. and Marina Bayeva: Genetics
* 5: Ozan Toy, Emmalee Boyle, and Lynn E. DeLisi: Inflammatory
mechanisms, the immune system and psychiatric illness
* 6: Shaun M. Eack: Psychological and social factors
* III. Pharmacotherapy
* 7: David. V. Braitman and Juan. R. Bustillo: Schizophrenia
* 8: Jair C. Soares, Marsal Sanches, and Rodrigo Machado-Vieira:
Pharmacotherapy of mood disorders
* 9: Dan J. Stein: Pharmacotherapy of anxiety and related disorders
* 10: Jenni E. Farrow, Francisco Romo-Nava, and Melissa Delbello: Child
and adolescent psychiatry
* IV. Psychosocial interventions
* 11: Kevin S. McCarthy and Richard F. Summers: Psychodynamic therapy
* 12: Keith S. Dobson: Cognitive behavioral therapy
* 13: Amanda A. Uliaszek, Nadia Al-Dajani, Amanda Ferguson, and Zindel
V. Segal: Third wave psychotherapies
* 14: Mariam Ujeyl and Wulf Rössler: Psychosocial rehabilitation
* 15: Neil Jordan: Social and community psychiatry
* 16: Mark R. Dadds, Yixin Jiang, Valsamma Eapen, and Stephen Scott:
Child and adolescent psychiatry and psychology
* VI. Somatic Treatments
* 17: Keith G. Rasmussen: Electroconvulsive therapy
* 18: Kevin A. Caulfield and Mark S. George: Non-convulsive brain
stimulation
* 19: Paul E. Holtzheimer and Helen Mayberg: Subcallosal cingulate deep
brain stimulation for treatment-resistant depression
* VII. Special Considerations
* 20: Rachel E. Zettl and John Z. Sadler: Psychiatric ethics
* 21: Stephen H. Dinwiddie: Forensics
* 22: Danuta Wasserman, Marcus Sokolowski, and Carli Vladimir: Suicide
* 23: Robert D. Gibbons: Research methodology